Caris Life Sciences/$CAI
13:30
15:10
16:45
18:25
20:00
1D1W1MYTD1Y5YMAX
About Caris Life Sciences
Caris Life Sciences Inc is a patient-centric, next-generation AI TechBio company. It develop and commercialize solutions to transform healthcare through the use of comprehensive molecular information and artificial intelligence/machine learning algorithms at scale.
Ticker
$CAI
Sector
Primary listing
Employees
1,846
Headquarters
Website
CAI Metrics
BasicAdvanced
$5.2bn
-
-$1.80
-
-
Price and volume
Market cap
$5.2bn
52-week high
$42.50
52-week low
$14.19
Average daily volume
3.1m
Financial strength
Current ratio
7.048
Quick ratio
6.352
Long term debt to equity
71.611
Total debt to equity
72.614
Interest coverage (TTM)
1.90%
Profitability
EBITDA (TTM)
128.981
Gross margin (TTM)
68.92%
Net profit margin (TTM)
3.75%
Operating margin (TTM)
11.94%
Effective tax rate (TTM)
-0.40%
Revenue per employee (TTM)
$490,000
Management effectiveness
Return on assets (TTM)
9.31%
Return on equity (TTM)
28.35%
Valuation
Price to revenue (TTM)
4.661
Price to book
8.8
Price to tangible book (TTM)
9.09
Price to free cash flow (TTM)
34.251
Free cash flow yield (TTM)
2.92%
Free cash flow per share (TTM)
0.539
Growth
Revenue change (TTM)
100.51%
Earnings per share change (TTM)
-82.78%
What the Analysts think about CAI
Analyst ratings (Buy, Hold, Sell) for Caris Life Sciences stock.
CAI Financial Performance
Revenues and expenses
CAI Earnings Performance
Company profitability
CAI News
AllArticlesVideos
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Real-time US market data is sourced from the IEX order book provided by Polygon. After-hours US market data is 15 minutes delayed and may differ significantly from the actual tradable price at market open.
FAQs